theory clinical_65_1
imports Main

begin

typedecl entity
typedecl event

consts
  Akt :: "entity ⇒ bool"
  Activated :: "entity ⇒ bool"
  CellularFunctions :: "entity ⇒ bool"
  Mediate :: "event ⇒ bool"
  Agent :: "event ⇒ entity ⇒ bool"
  Patient :: "event ⇒ entity ⇒ bool"
  Include :: "entity ⇒ entity ⇒ bool"
  Proliferation :: "entity"
  Survival :: "entity"
  Alpelisib :: "entity ⇒ bool"
  KinaseInhibitor :: "entity ⇒ bool"
  BreastCancers :: "entity ⇒ bool"
  UsedFor :: "entity ⇒ entity ⇒ bool"
  In :: "entity ⇒ entity ⇒ bool"
  Mutations :: "entity ⇒ bool"
  PI3K_AKT_Pathway :: "entity ⇒ bool"
  Target :: "event ⇒ bool"
  Inhibit :: "event ⇒ bool"

(* Explanation 1: Fully activated Akt mediates numerous cellular functions including proliferation and survival. *)
axiomatization where
  explanation_1: "∃x y e. Akt x ∧ Activated x ∧ CellularFunctions y ∧ Mediate e ∧ Agent e x ∧ Patient e y ∧ Include y Proliferation ∧ Include y Survival"

(* Explanation 2: Alpelisib is a kinase inhibitor used in the treatment of certain breast cancers. *)
axiomatization where
  explanation_2: "∃x y z. Alpelisib x ∧ KinaseInhibitor y ∧ BreastCancers z ∧ UsedFor y z ∧ In x y"

theorem hypothesis:
  assumes asm: "KinaseInhibitor x ∧ Mutations y ∧ PI3K_AKT_Pathway z"
  (* Hypothesis: Using a kinase inhibitor may target mutations in the PI3K/AKT pathway and inhibit proliferation and survival. *)
  shows "∃x y z e1 e2. KinaseInhibitor x ∧ Mutations y ∧ PI3K_AKT_Pathway z ∧ Target e1 ∧ Agent e1 x ∧ Patient e1 y ∧ In y z ∧ Inhibit e2 ∧ Agent e2 x ∧ Patient e2 y"
proof -
  (* From the premise, we have information about a kinase inhibitor, mutations, and the PI3K/AKT pathway. *)
  from asm have "KinaseInhibitor x ∧ Mutations y ∧ PI3K_AKT_Pathway z" by simp
  (* Explanation 1 tells us that fully activated Akt mediates cellular functions including proliferation and survival. *)
  (* Explanation 2 tells us that Alpelisib is a kinase inhibitor used in the treatment of certain breast cancers. *)
  (* We can infer that using a kinase inhibitor can target mutations in the PI3K/AKT pathway and inhibit proliferation and survival. *)
  then have "∃e1 e2. Target e1 ∧ Agent e1 x ∧ Patient e1 y ∧ In y z ∧ Inhibit e2 ∧ Agent e2 x ∧ Patient e2 Proliferation ∧ Agent e2 x ∧ Patient e2 Survival" sledgehammer
  then show ?thesis <ATP>
qed

end
